CMV VACCINES

Provided herein are genetically modified arenaviral vectors for use in a method for prevention and treatment of cytomegalovirus infections. In particular, the method comprises administering to a subject a first infectious, replication-deficient arenavirus viral vector, and the method further compris...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Hauptverfasser:	BAUMGARTL-STRASSER, VERA, GUIRAKHOO, FARSHAD, WATSON, ELIZABETH, KAINER, MANUELA, MONATH, THOMAS, COHEN, KATHERINE, ASPÖCK, ANDREAS, FUHRMANN, GERHARD, ORLINGER, KLAUS, KIEFMANN, BETTINA, LINGNAU, KAREN, BRIM, BERNHARD, MÜHLBACHER, ELSA, AISTLEITHNER, MARIO, BAYER, KATHARINA
Format:	Patent
Sprache:	eng ; srp
Schlagworte:	BEER BIOCHEMISTRY CHEMISTRY COMPOSITIONS THEREOF CULTURE MEDIA ENZYMOLOGY HUMAN NECESSITIES HYGIENE MEDICAL OR VETERINARY SCIENCE METALLURGY MICROBIOLOGY MICROORGANISMS OR ENZYMES MUTATION OR GENETIC ENGINEERING PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES PROPAGATING, PRESERVING OR MAINTAINING MICROORGANISMS SPIRITS VINEGAR WINE
Online-Zugang:	Volltext bestellen
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Beschreibung
Zusammenfassung:	Provided herein are genetically modified arenaviral vectors for use in a method for prevention and treatment of cytomegalovirus infections. In particular, the method comprises administering to a subject a first infectious, replication-deficient arenavirus viral vector, and the method further comprises administering to the subject a second infectious, replication-deficient arenavirus viral vector.